Poster Abstract Session:
138. Adult Immunization - Miscellaneous
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Development of a Novel Anthrax Vaccine Comprising LF-PA Chimera
Somya Aggarwal, Ph.D; Vikas Somani, Ph.D; Rakesh Bhatnagar, Ph.D
Phase 1 Clinical Trial of a Replication-Defective Human Cytomegalovirus (CMV) Vaccine
Stuart Adler, MD; Nicole Lewis, MS; Anthony Conlon, PhD; Mark Christiansen, MD; Mohamed S. Al-Ibrahim, MB, ChB; Richard Rupp, MD; Tong Ming Fu, MD; Oliver Bautista, PhD; Huaping Tang, PhD; Timothy Culp, PhD; Rituparna Das, MD; Karen Beck, RN, BSN; Gretchen Tamms, BS; Luwy Musey, MD
  • 17-1559 ID WEEK - Adler.png (186.6 kB)
  • Sustained Lesion and Shedding Rate Reductions in Genital Herpes Patients 24 Months after Immunization with GEN-003, a Genital Herpes Immunotherapy
    Thomas Heineman, MD, PhD; Lisa K. Mcneil, PhD; Thomas Oliphant, MS, PhD; Andrew Natenshon, MA; Nicholas Van Wagoner, MD, PhD; Jessica B. Flechtner, PhD; Seth Hetherington, MD
    Estimating the health and economic impact of universal varicella vaccination in Jordan
    Wail Hayajneh, MD; Mohammad Al Abdullat, MD; Abdalla Al Shurman, MD; Jihane Maalouf, RPH; Barbara Kuter, PhD, MPH; Tracey Weiss, MPH; Vince Daniels, PhD; Lara Wolfson, PhD
    Serum and lung pharmacokinetics of ASN100, a monoclonal antibody combination for the prevention and treatment of Staphylococcus aureus pneumonia
    Zoltan Magyarics, M.D., Ph.D.; Fraser Leslie, BCPS; Steven A. Luperchio, Ph.D., CMPP; Johann Bartko, MD; Christian Schörgenhofer, MD; Michael Schwameis, MD; Ulla Derhaschnig, MD; Heimo Lagler, MD; Leopold Stiebellehner, MD; Bernd Jilma, MD PhD; Christopher Stevens, M.D.; Eszter Nagy, MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.